✦ LIBER ✦

Bromocriptine in patients with chronic autoimmune-associated disorders

✍ Scribed by Schaaf, L. ;Zierhut, M. ;Baur, E. -M. ;Geissler, W. ;Thiel, H. J. ;Scif, F. J. ;Usadel, K. H.

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 109 KB
Volume: 69
Category: Article
ISSN: 1432-1440
DOI: 10.1007/bf01798549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myelodysplastic syndrome associated with

Myelodysplastic syndrome associated with multiple autoimmune disorders

✍ Dimitrios Farmakis; Evaggelos Polymeropoulos; Aikaterini Polonifi; Spyros Defter 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 210 KB

Autoimmune thyroid diseases in patients

Autoimmune thyroid diseases in patients with chronic fasciolosis

✍ Mustafa Demirci; S. Ercan Tune; Namik Delibas; M. Numan Tamer; Irfan Altuntas; M 📂 Article 📅 2003 🏛 Springer Vienna 🌐 English ⚖ 75 KB

The neurological disorder associated wit

The neurological disorder associated with thyroid autoimmunity

✍ Franco Ferracci; Antonio Carnevale 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 183 KB

Cyclosporin-associated nephropathy in pa

Cyclosporin-associated nephropathy in patients with autoimmune diseases

✍ Mihatsch, M. J. ;Bach, J. F. ;Coovadia, H. M. ;Førre, Ø. ;Moutsopoulos, H. M. ;D 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 568 KB

CTLA-4 exon 1 polymorphism in patients w

CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders

✍ Marica Pavkovic; Borce Georgievski; Lidija Cevreska; Mirko Spiroski; Dimitar G. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Relapse Following Treatment Withdrawal i

Relapse Following Treatment Withdrawal in Patients with Autoimmune Chronic Active Hepatitis

✍ John E. Hegarty; Kayhan T. Nouri Aria; Bernard Portmann; Adrian L. W. F. Eddlest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

A prospective study was performed to evaluate the outcome of treatment withdrawal in 30 patients with "autoimmune" chronic active hepatitis in remission for periods of 1.5 to 9 years on maintenance corticosteroid and azathioprine therapy. Reactivation of disease, with marked rises in serum aminotran